Nathaniel R Smilowitz1, Carlos L Alviar2, Stuart D Katz2, Judith S Hochman2. 1. Leon H. Charney Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, NY; Division of Cardiology, Department of Medicine, Veterans Affairs New York Harbor Health Care System, New York, NY. Electronic address: nathaniel.smilowitz@nyulangone.org. 2. Leon H. Charney Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, NY.
Abstract
BACKGROUND: Myocardial infarction (MI) complicated by cardiogenic shock (CS) is associated with high mortality. Early coronary revascularization improves survival, but the optimal mode of revascularization remains uncertain. We sought to characterize practice patterns and outcomes of coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) in patients with MI complicated by CS. METHODS: Patients hospitalized for MI with CS between 2002 and 2014 were identified from the United States National Inpatient Sample. Trends in management were evaluated over time. Propensity score matching was performed to identify cohorts with similar baseline characteristics and MI presentations who underwent PCI and CABG. The primary outcome was in-hospital all-cause mortality. RESULTS: A total of 386,811 hospitalizations for MI with CS were identified; 67% were STEMI. Overall, 62.4% of patients underwent revascularization, with PCI in 44.9%, CABG in 14.1%, and a hybrid approach in 3.4%. Coronary revascularization for MI and CS increased over time, from 51.5% in 2002 to 67.4% in 2014 (P for trend < .001). Patients who underwent CABG were more likely to have diabetes mellitus (35.5% vs. 29.2%, P < .001) and less likely to present with STEMI (48.7% vs. 80.9%, P < .001) than those who underwent PCI. CABG (without PCI) was associated with lower mortality than PCI (without CABG) overall (18.9% vs. 29.0%, P < .001) and in a propensity-matched subgroup of 19,882 patients (19.0% vs. 27.0%, P < .001). CONCLUSIONS: CABG was associated with lower in-hospital mortality than PCI among patients with MI complicated by CS. Due to the likelihood of residual confounding, a randomized trial of PCI versus CABG in patients with MI, CS, and multi-vessel coronary disease is warranted. Published by Elsevier Inc.
BACKGROUND:Myocardial infarction (MI) complicated by cardiogenic shock (CS) is associated with high mortality. Early coronary revascularization improves survival, but the optimal mode of revascularization remains uncertain. We sought to characterize practice patterns and outcomes of coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) in patients with MI complicated by CS. METHODS:Patients hospitalized for MI with CS between 2002 and 2014 were identified from the United States National Inpatient Sample. Trends in management were evaluated over time. Propensity score matching was performed to identify cohorts with similar baseline characteristics and MI presentations who underwent PCI and CABG. The primary outcome was in-hospital all-cause mortality. RESULTS: A total of 386,811 hospitalizations for MI with CS were identified; 67% were STEMI. Overall, 62.4% of patients underwent revascularization, with PCI in 44.9%, CABG in 14.1%, and a hybrid approach in 3.4%. Coronary revascularization for MI and CS increased over time, from 51.5% in 2002 to 67.4% in 2014 (P for trend < .001). Patients who underwent CABG were more likely to have diabetes mellitus (35.5% vs. 29.2%, P < .001) and less likely to present with STEMI (48.7% vs. 80.9%, P < .001) than those who underwent PCI. CABG (without PCI) was associated with lower mortality than PCI (without CABG) overall (18.9% vs. 29.0%, P < .001) and in a propensity-matched subgroup of 19,882 patients (19.0% vs. 27.0%, P < .001). CONCLUSIONS: CABG was associated with lower in-hospital mortality than PCI among patients with MI complicated by CS. Due to the likelihood of residual confounding, a randomized trial of PCI versus CABG in patients with MI, CS, and multi-vessel coronary disease is warranted. Published by Elsevier Inc.
Authors: Vasim Farooq; Patrick W Serruys; Christos V Bourantas; Yaojun Zhang; Takashi Muramatsu; Ted Feldman; David R Holmes; Michael Mack; Marie Claude Morice; Elisabeth Ståhle; Antonio Colombo; Ton de Vries; Marie-angèle Morel; Keith D Dawkins; Arie-Pieter Kappetein; Friedrich W Mohr Journal: Circulation Date: 2013-06-13 Impact factor: 29.690
Authors: Holger Thiele; Ibrahim Akin; Marcus Sandri; Georg Fuernau; Suzanne de Waha; Roza Meyer-Saraei; Peter Nordbeck; Tobias Geisler; Ulf Landmesser; Carsten Skurk; Andreas Fach; Harald Lapp; Jan J Piek; Marko Noc; Tomaž Goslar; Stephan B Felix; Lars S Maier; Janina Stepinska; Keith Oldroyd; Pranas Serpytis; Gilles Montalescot; Olivier Barthelemy; Kurt Huber; Stephan Windecker; Stefano Savonitto; Patrizia Torremante; Christiaan Vrints; Steffen Schneider; Steffen Desch; Uwe Zeymer Journal: N Engl J Med Date: 2017-10-30 Impact factor: 91.245
Authors: Shamir R Mehta; David A Wood; Robert F Storey; Roxana Mehran; Kevin R Bainey; Helen Nguyen; Brandi Meeks; Giuseppe Di Pasquale; Jose López-Sendón; David P Faxon; Laura Mauri; Sunil V Rao; Laurent Feldman; P Gabriel Steg; Álvaro Avezum; Tej Sheth; Natalia Pinilla-Echeverri; Raul Moreno; Gianluca Campo; Benjamin Wrigley; Sasko Kedev; Andrew Sutton; Richard Oliver; Josep Rodés-Cabau; Goran Stanković; Robert Welsh; Shahar Lavi; Warren J Cantor; Jia Wang; Juliet Nakamya; Shrikant I Bangdiwala; John A Cairns Journal: N Engl J Med Date: 2019-09-01 Impact factor: 91.245
Authors: Deepak Acharya; Brian C Gulack; Renzo Y Loyaga-Rendon; James E Davies; Xia He; J Matthew Brennan; Vinod H Thourani; Matthew L Williams Journal: Ann Thorac Surg Date: 2015-12-22 Impact factor: 4.330
Authors: David D Berg; Erin A Bohula; Sean van Diepen; Jason N Katz; Carlos L Alviar; Vivian M Baird-Zars; Christopher F Barnett; Gregory W Barsness; James A Burke; Paul C Cremer; Jennifer Cruz; Lori B Daniels; Andrew P DeFilippis; Affan Haleem; Steven M Hollenberg; James M Horowitz; Norma Keller; Michael C Kontos; Patrick R Lawler; Venu Menon; Thomas S Metkus; Jason Ng; Ryan Orgel; Christopher B Overgaard; Jeong-Gun Park; Nicholas Phreaner; Robert O Roswell; Steven P Schulman; R Jeffrey Snell; Michael A Solomon; Bradley Ternus; Wayne Tymchak; Fnu Vikram; David A Morrow Journal: Circ Cardiovasc Qual Outcomes Date: 2019-03
Authors: Siddharth A Wayangankar; Sripal Bangalore; Lisa A McCoy; Hani Jneid; Faisal Latif; Wassef Karrowni; Konstantinos Charitakis; Dmitriy N Feldman; Habib A Dakik; Laura Mauri; Eric D Peterson; John Messenger; Mathew Roe; Debabrata Mukherjee; Andrew Klein Journal: JACC Cardiovasc Interv Date: 2016-01-20 Impact factor: 11.195
Authors: J S Hochman; J Boland; L A Sleeper; M Porway; J Brinker; J Col; A Jacobs; J Slater; D Miller; H Wasserman Journal: Circulation Date: 1995-02-01 Impact factor: 29.690